Research Offers Promising Outlook for Nanomedicine – Controlled Environments Magazine

In the past six years, the National Research Programme "Opportunities and Risks of Nanomaterials" (NRP 64) intensively studied the development, use, behavior, and degradation of engineered nanomaterials, including their impact on humans and on the environment.

Twenty-three research projects on biomedicine, the environment, energy, construction materials and food demonstrated the enormous potential of engineered nanoparticles for numerous applications in industry and medicine. Thanks to these projects we now know a great deal more about the risks associated with nanomaterials and are therefore able to more accurately determine where and how they can be safely used.

"One of the specified criteria in the program was that every project had to examine both the opportunities and the risks, and in some cases this was a major challenge for the researchers," explains Peter Gehr, President of the NRP 64 Steering Committee.

One development that is nearing industrial application concerns a building material strengthened with nanocellulose that can be used to produce a strong but lightweight insulation material. Successful research was also carried out in the area of energy, where the aim was to find a way to make lithium-ion batteries safer and more efficient.

A great deal of potential is predicted for the field of nanomedicine. Nine of the 23 projects in NRP 64 focused on biomedical applications of nanoparticles. These include their use for drug delivery, for example in the fight against viruses, or as immune modulators in a vaccine against asthma. Another promising application concerns the use of nanomagnets for filtering out harmful metallic substances from the blood. One of the projects demonstrated that certain nanoparticles can penetrate the placenta barrier, which points to potential new therapy options. The potential of cartilage and bone substitute materials based on nanocellulose or nanofibres was also studied.

The examination of potential health risks was the focus of NRP 64. A number of projects examined what happens when nanoparticles are inhaled, while two focused on ingestion. One of these investigated whether the human gut is able to absorb iron more efficiently if it is administered in the form of iron nanoparticles in a food additive, while the other studied silicon nanoparticles as they occur in powdered condiments. It was ascertained that further studies will be required in order to determine the doses that can be used without risking an inflammatory reaction in the gut.

The aim of the seven projects focusing on environmental impact was to gain a better understanding of the toxicity of nanomaterials and their degradability, stability and accumulation in the environment and in biological systems. Here, the research teams monitored how engineered nanoparticles disseminate along their lifecycle, and where they end up or how they can be discarded.

One of the projects established that 95 percent of silver nanoparticles that are washed out of textiles are collected in sewage treatment plants, while the remaining particles end up in sewage sludge, which in Switzerland is incinerated. In another project a measurement device was developed to determine how aquatic microorganisms react when they come into contact with nanoparticles.

"The findings of the NRP 64 projects form the basis for a safe application of nanomaterials," says Christoph Studer from the Federal Office of Public Health. "It has become apparent that regulatory instruments such as testing guidelines will have to be adapted at both national and international level." Studer has been closely monitoring the research program in his capacity as the Swiss government's representative in NRP 64. In this context, the precautionary matrix developed by the government is an important instrument by means of which companies can systematically assess the risks associated with the use of nanomaterials in their production processes.

The importance of standardized characterization and evaluation of engineered nanomaterials was highlighted by the close cooperation among researchers in the program. "The research network that was built up in the framework of NRP 64 is functioning smoothly and needs to be further nurtured," says Professor Bernd Nowack from Empa, who headed one of the 23 projects.

The results of NRP 64 show that new key technologies such as the use of nanomaterials need to be closely monitored through basic research due to the lack of data on its long-term effects. As Gehr points out, "We now know a lot more about the risks of nanomaterials and how to keep them under control. However, we need to conduct additional research to learn what happens when humans and the environment are exposed to engineered nanoparticles over longer periods, or what happens a long time after a one-off exposure."

Source: Swiss National Science Foundation

Read more:
Research Offers Promising Outlook for Nanomedicine - Controlled Environments Magazine

Vitamin Research – UNIV OF WISCONSIN

Progress 10/01/06 to 09/30/11

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas is described below. Project 1. Both nutritional and genetic approaches are being used to determine how vitamin A functions in developing embryos, neonates and adults. Our laboratory has developed animal models to study vitamin A function in both early and late embryonic processes, as well as during postnatal life. We have shown that vitamin A is required for the initiation of meiosis in both the female and male gonad. Additionally, we identified several retinoic acid responsive genes that are expressed in the nervous system of developing embryos and in the adult brain. One of these, neuron navigator 2 (Nav2 or retinoic acid-induced in neuroblastoma, RAINB1), plays an essential role in neurite outgrowth, and in the development of the cranial nerves, eye, and brain. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects. In collaboration with our colleagues at the OSU, we have shown that the carbon-linked 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), does not need to be hydrolyzed back to atRA to function in culture or in vivo. Mechanistic microarray studies are underway to determine how these compounds work in cultured breast cancer cells and mammary tumors. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of acne and other disease states. Using the Rhino mouse as a model, we have identified a unique subset of vitamin D analogs that induce comedolysis. Studies are underway to determine how vitamin D compounds act to produce these effects. PARTICIPANTS: Jamie Ahrens (Senior research specialist), Elizabeth McNeill (Research associate), Danielle Knutsion (Research associate), Allyson Anding (Research assistant), Melissa Rohrer (Research associate), Mark Marzinke (Research assistant), Nirca Nieves (Research associate), Jim James (Associate research specialist), Mariana Bormann (Associate research specialist) TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. Rather than striving only to prevent overt nutrient deficiency, we need to begin to develop an understanding of "optimal" levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus, studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

Progress 01/01/09 to 12/31/09

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas is described below. Project 1. Both nutritional and genetic approaches are being used to determine how and when vitamin A is needed for developing embryos, neonates and adults. Our laboratory has developed methods that enable the study of vitamin A function in both early and late embryonic processes, and more recently during postnatal life. When limiting amounts of atRA are provided after embryonic day (E) 10.5 in the rat, a highly reproducible and penetrant state of late fetal vitamin A-deficiency (VAD) is produced in the organs of developing fetuses. Using this method, we have recently shown that vitamin A is required for the initiation of meiosis in the female gonad. In addition, we have published a detailed characterization of the molecular events that are perturbed in the developing eye when insufficient vitamin A is present. We are also studying the function of several novel atRA responsive genes, and have shown that one of these genes (RAINB1 also known as Nav2) plays an essential role in neurite outgrowth, and in the development of the cranial nerves, eye, and brain. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects. In collaboration with our colleagues at the OSU, we have shown that the carbon-linked 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), does not need to be hydrolyzed back to atRA to function in culture or in vivo. Further, 4-HBR is less toxic than 4-HPR, and appears to act by inducing ER stress-mediated responses. Work to further elucidate the cellular pathways that are altered by 4-HBR is underway, as are studies of its effects in developing embryos. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of acne. Using the Rhino mouse as a model, the ability of compounds to produce a reduction in comedone size is being studied. Whereas all vitamin D analogs appear to induce thickening of the epidermis, we have identified a unique subset of analogs that also induce comedolysis. Studies are underway to determine how vitamin D compounds act to produce these effects. PARTICIPANTS: Angela See, Postdoctoral fellow; current employment Nimblegen; Hui Li, Postdoctoral fellow; Melissa Rohrer, Posdotoral fellow; Elizabeth McNeill, completed PhD; Nirca Nieves, completed PhD; Allyson Anding, PhD training ongoing; Mark Marzinke, PhD training ongoing TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. Rather than striving only to prevent overt nutrient deficiency, we need to begin to develop an understanding of "optimal" levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

Progress 01/01/08 to 12/31/08

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas are described below. Project 1. Both nutritional and genetic approaches are being used to determine how and when vitamin A is needed for developing embryos, neonates and adults. Our laboratory has developed methods that enable the study of vitamin A function in both early and late embryonic processes, and more recently during postnatal life. Our recently published work shows that when limiting amounts of atRA are provided after embryonic day (E) 10.5 in the rat, a highly reproducible and penetrant state of late fetal vitamin A-deficiency (VAD) is produced in the organs of developing fetuses. This work shows that a large number of organ systems are adversely affected, including the eye. The optic fissure does not close, and severe folding and collapse of the retina is observed at E18.5. In our most recent work, we show that coloboma and retinal folding represent distinct VAD-dependent effects. The downregulation of Pitx2 in VAD may be related to the failure of the optic fissure to close, whereas a reduction in cyclin D1 and the cell adhesion molecules, N-cadherin and B-catenin, may play a role in the retinal thinning, folding and collapse observed in late VAD fetuses. We are also studying the function of several novel atRA responsive genes, and have found that one of these genes (RAINB1) plays an essential role in neurite outgrowth, and in the development of the cranial nerves, eye, and brain. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects on cancer cells. In collaboration with our colleagues at the OSU, we have found that the carbon-linked 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), does not need to be hydrolyzed back to atRA to function in culture or in vivo. Our studies also indicate that 4-HBR is less toxic than 4-HPR. Recently, we reported that 4-HBR rapidly induces ER stress-mediated responses and this may represent a mechanism whereby this compound produces its chemotherapeutic effects. Work to further elucidate the cellular pathways that are altered by 4-HBR is underway. Studies of additional nonhydrolyzable compounds, including glucuronide and glucose derivatives of 4-HBR are also ongoing. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of acne. Using the Rhino mouse as a model, the ability of compounds to produce a reduction in comedone size is being studied. We have identified a specific subset of vitamin D analogs that are effective in this model. Studies are underway to determine how vitamin D compounds act to induce comedolysis. PARTICIPANTS: See - PhD received 2008: Knutson - PhD received 2008 Muley - completed postdoctoral training; McNeill - PhD in progress TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. It is becoming abundantly clear that rather than striving only to prevent overt nutrient deficiency, that we need to begin to develop an understanding of "optimal" levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

Progress 01/01/07 to 12/31/07

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas is described below. Project 1. Both nutritional and genetic approaches are being used to determine how and when vitamin A is needed for developing embryos. Our laboratory has developed methods that enable the study of vitamin A function in both early and late embryonic processes. Using this model, we have shown that vitamin A plays a critical early role in patterning the heart, hindbrain and axial skeleton. Our recently published work shows that when limiting amounts of atRA are provided after embryonic day 10.5 in the rat, a highly reproducible and penetrant state of late fetal vitamin A-deficiency (VAD) is produced in the organs of developing fetuses. These fetuses also display anteriorization of cervical regions of the skeleton and novel posteriorization events at the thoracic and sacral levels, and also show sternal and pelvic malformations not previously observed in genetic models. We are now using these nutritional models to explore the molecular mechanisms that are disrupted by embryonic vitamin A-deficiency. We are also studying the distribution and function of novel atRA responsive genes, and have found that one of these genes (RAINB1) plays an essential role in neurite outgrowth. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects on cancer cells. In collaboration with our colleagues at the OSU, we have found that the carbon-linked 4-HPR analog (4-HBR) does not need to be hydrolyzed back to atRA to function in culture or in vivo. Studies of the efficacy 4-HBR in chemotherapy of DMBA-induced mammary tumors in the rat show that the non-hydrolysable analog is equally effective in reducing tumor size and number, and does so without reducing blood retinol levels, an undesirable side affect associated with the use of the parent compound, 4-HPR. Although 4-HBR can bind and transactivate RARs, this is not required for it to induce cell death. Recently, we reported that 4-HBR rapidly induces ER stress-mediated responses and may represent a mechanism whereby this compound produces its chemotherapeutic effects. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of disease. One example is the use of retinoids for the treatment of acne. A major limitation to current oral therapy is teratogenic liability. As a potential improvement, we are studying sterically hindered vitamin A analogs. Using the Rhino mouse as a model, the ability of compounds to produce a reduction in comedone size is being studied. We have also found that some vitamin D analogs are effective in this model. Studies are underway to determine whether these approaches may offer any advantage to existing therapies. PARTICIPANTS: J. Ahrens, Research Specialist M. Kaiser, Senior Research Specialist In Training E. McNeill, Research Asst A. See, Research Asst N. Nieves, Research Asst A. Anding, Research Asst D. Knutson, Research Asst TARGET AUDIENCES: Biochemical, Cellular and Molecular and Medical Research Communities, with the Intent of Increasing Knowledge, as well as, to Capitalize on the Translational Value of this Research.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. It is becoming abundantly clear that rather than striving only to prevent overt nutrient deficiency, that we need to begin to develop an understanding of "optimal" levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

The rest is here:
Vitamin Research - UNIV OF WISCONSIN

Unscrambling The Nutrition Science On Eggs – NPR

As more research suggests some degree of dietary cholesterol is harmless, if not healthy, the egg's reputation is slowly returning. Yet some experts worry the science is being misinterpreted and spun. Kelly Jo Smart/NPR hide caption

As more research suggests some degree of dietary cholesterol is harmless, if not healthy, the egg's reputation is slowly returning. Yet some experts worry the science is being misinterpreted and spun.

Historically, when humans have sought a reliable source of calories particularly one that can be readily nabbed from an unsuspecting animal with minimal exertion and zero horticulture skills we have often turned to eggs.

We've pilfered the ova of countless creatures since Neolithic times. But it is the nutritive and symbolic capacities of the humble bird egg, primarily that of the chicken, that we have most consistently championed: reliable nourishment, a hangover cure, an emblem of rebirth when necessary, a supreme projectile.

As P.G. Wodehouse asked in his 1906 novel, Love Among The Chickens, "Have you ever seen a man, woman, or child who wasn't eating an egg or just going to eat an egg or just coming away from eating an egg? I tell you, the good old egg is the foundation of daily life."

Yet in the late 1970s, our egg appreciation soured. Doctors realized that excess cholesterol in our blood predicts a higher risk of heart disease. Cholesterol is a fatty substance necessary for digestion, cellular function and the production of hormones. When too much of it shuttles through our blood supply, it can accumulate on artery walls and up our risk for heart attack and stroke. By extension, many physicians of the day assumed that eating high-cholesterol foods like butter, red meat and eggs was probably disastrous for our health and should be avoided. Fat phobia ensued.

We now know it's more complicated than this.

Cholesterol no doubt contributes to heart disease by literally blocking our blood vessels. And eating cholesterol can raise levels of it in the blood, but, as a growing body of research has shown, not by that much. Consuming sugar, transfats or excessive saturated fat can be more harmful to cholesterol levels than dietary cholesterol itself. Most of the cholesterol in our bodies we make ourselves in the liver, and total body levels are heavily influenced by genetics, gender and age.

As more and more research suggests that some degree of cholesterol consumption is harmless, if not healthy, the egg's reputation is gradually returning. Yet some experts worry that the science is being misinterpreted and spun by the media, the egg industry and even opportunistic doctors. Diet science tends to be presented and perceived as black or white. Take butter: bad for us one day, not so bad the next. It's an eternal cycle of self-help revenue. Unfortunately, health and science are rarely this simple. And neither is the egg.

Our collective fear of cholesterol and other fats in part traces back to results from the famous Framingham Heart Study. Launched in 1948 and still going today, the study began by tracking the lifestyles of 5,209 people from Framingham, Mass. The results, which began to appear in journals in the early 1960s, led to our current understanding of heart health and how it's affected by factors like exercise, smoking and diet.

Dr. Walter Willett, chair of the Harvard T.H. Chan School of Public Health's Nutrition Department, was one of the first physicians to realize that while the Framingham findings showed that cholesterol in the blood is associated with a higher risk of heart disease, no studies at that point had shown that cholesterol consumption actually increased blood levels.

Willett and his colleagues have since studied thousands of patients for years and have found no evidence that moderate dietary cholesterol or egg consumption increases the risk for heart disease and stroke, except in people with a strong genetic risk for high cholesterol and possibly people with diabetes.

His findings echo those from a 2013 study published in BMJ reporting that eating one egg per day is not associated with impaired heart health.

"There is now general consensus that dietary cholesterol, primarily consumed in eggs, and to a lesser extent in certain seafoods like shrimp, has a relatively small effect in raising blood cholesterol," explains Dr. Bruce Griffin, who studies the links between nutrition and cardiovascular disease at the University of Surrey in England. Griffin's own study from 2009 found that overweight people prescribed a low-calorie diet that included two eggs a day actually saw a drop in cholesterol levels.

The renaissance around cholesterol is not lost on guideline committees, many of which are softening their stance.

In 2013 the American College of Cardiology and American Heart Association rattled the medical community by releasing new cholesterol guidelines that abandoned the long-standing goal of keeping our "bad cholesterol" our LDLs under 100. The guideline authors based their decision on the lack of randomized-controlled trials supporting a specific target. Too many LDLs tumbling through our bloodstream are no doubt bad, they acknowledge, but dangerous levels in one person might be tolerable in someone else. Also, chasing a specific target through overtreatment could subject patients to drug side effects, which need to be considered.

The 2015 Dietary Guidelines for Americans co-developed by the U.S. Department of Agriculture and U.S. Department of Health and Human Services also broke with tradition. General clinical dogma had previously held that total cholesterol should be capped at 300 milligrams per day in healthy people, roughly the amount found in 1 1/2 average-sized chicken eggs. Yet the new guidelines don't include a specific numerical goal. As the authors wrote, "available evidence shows no appreciable relationship between consumption of dietary cholesterol and [blood] cholesterol ... Cholesterol is not a nutrient of concern for overconsumption."

But some nutrition scientists worry that this softened official line on cholesterol sends the wrong message.

"The lack of dietary cholesterol recommendations in recently released ... guidelines is controversial," says Dr. Wahida Karmally, director of nutrition at the Irving Institute for Clinical and Translational Research at Columbia University. "This should not be interpreted as an affirmation to ignore dietary cholesterol, since there is clear evidence that it does increase LDL-cholesterol," she says.

And it does. But by some estimates, only by around 10 percent.

Karmally also points out the danger in generalizing study results to the entire population. She notes that a significant portion of population up to 30 percent, some estimate are thought to be "hyper-responders," meaning they experience abnormally high spikes in blood cholesterol as a result of consuming cholesterol. Most experts agree that hyper-responders need to be especially diligent about limiting cholesterol consumption.

Dr. J. David Spence, a professor of neurology and clinical pharmacology at Western University in London, Ontario, a known egg detractor, is livid at how the 2015 guidelines were interpreted.

"The egg industry and the media seized on the first paragraph of the media release of the new guideline, which said there is not strong data on which to base a specific numerical limit to a dietary cholesterol intake," he points out. "But if we read on, the guidelines recommend that cholesterol intake should be as low as possible and part of a generally healthy diet."

The report also cautions that foods high in cholesterol are often also high in saturated fat, which itself increases blood cholesterol and the risk of heart disease.

Spence likens Big Egg to Big Tobacco in its loose interpretation of scientific data in the interest of profit.

In December 2016, a meta-analysis published in the Journal of the American College of Nutrition reported that people who eat an average of one egg a day have a 12 percent lower risk for stroke compared with those who eat fewer eggs. The study also found no link, whether positive or negative, between egg consumption and coronary heart disease.

Yet note the fine print: The study was partially funded by something called the Egg Nutrition Center, a self-described "nutrition education division of the American Egg Board (AEB), a national checkoff program on all egg farms with more than 75,000 hens."

"I am not trying to put egg farmers out of business," says Spence. "[But] the propaganda of the egg industry rests on a half-truth."

He is referring to the fact that many past studies funded by the egg industry that support egg consumption measured fasting cholesterol levels rather than levels after a meal. Most of us spend a good portion of our day in a post-meal state, when our cholesterol climbs to higher levels and when it presumably does more damage to our arteries. What's more, by not measuring cholesterol after meals, researchers are unable to identify the hyper-responders, for whom consuming cholesterol poses added health risks.

Spence's true gripe lies not with the egg itself, but with the yolk. One jumbo egg yolk contains around 240 milligrams of cholesterol, nearly as much as an entree I was frightened to Google: the "2/3 lb. Hardee's Monster Thickburger." In an email, Spence recommended I try his omelet and frittata recipes while writing this article. Both are made with egg whites, which he cedes is a healthy source of protein.

Cholesterol aside, Willett points to other possible health benefits of eggs. They contain some unsaturated fats, associated with a lower risk of heart disease; also iron and a number of vitamins and minerals. And a new Finnish study one not affiliated with the egg industry even suggests that eating one egg a day could improve long-term cognitive function.

"Overall it is hard to say that eggs are good or bad," says Willett. "They're almost certainly no worse than sugary breakfast cereal or a bagel with cream cheese probably better. In terms of health, they seem to be in the middle somewhere."

However, in the interest of a healthy breakfast, before cracking into an egg, Willett says to consider fruit, nuts and whole grains, all thought to lower blood cholesterol and the risk of heart disease.

"A bowl of steel cut oats topped with nuts and berries will almost certainly reduce risk of heart disease compared to a breakfast centered on eggs," he says. "That's what I have most mornings, sometimes adding a bit of yogurt. But eggs are clearly not a poison pill."

Bret Stetka is a writer based in New York and an editorial director at Medscape. His work has appeared in Wired and Scientific American, and on The Atlantic.com. He graduated from the University of Virginia School of Medicine in 2005. He's also on Twitter: @BretStetka

More:
Unscrambling The Nutrition Science On Eggs - NPR

Nanomedicine provides HIV treatment alternative – Healio

The results of two trials, which examined the use of nanotechnology to improve drug therapies for HIV patients, found that a new nanomedicine method has the potential to cut the dose of leading HIV treatment in half, according to new evidence presented at the Conference of Retroviruses and Opportunistic Infections.

Nanomedicine, the application of nanotechnology to prevent and treat disease, can be used to develop smaller pills that are better for patients who experience high pill burden, like those with HIV, and less expensive to manufacture.

Led by the University of Liverpool in collaboration with the St. Stephens AIDS Trust at the Chelsea & Westminster Hospital in London, researchers examined the use of orally dosed nanomedicine to better deliver drugs to patients with HIV. Because there is a high pill burden associated with treating HIV, nanomedicine, with the potential to develop smaller pills that are better for patients and less expensive to make, can change how the disease is managed.

To develop these new oral therapies, the investigators used Solid Drug Nanoparticle (SDN) technology, which can improve drug absorption into the body and lead to reductions in the dose and cost per dose. According to the trial results, using new approaches to formulation of efavirenz (EFV) and lopinavir (LPV) can potentially cut the dose of leading HIV treatment 50% while still maintaining therapeutic exposure. This University of Liverpool-led trial correlates with their work as part of OPTIMIZE, the global partnership working to improve access to simpler, safer and more affordable HIV treatment.

By aligning efforts, these integrated investments offer the potential to reduce the doses required to control the HIV virus even further, resulting in real benefits globally, Benny Kottiri, MD, division chief of USAIDs office of HIV/AIDS research, said in the press release. This would enable the costs of therapy to be reduced, which is particularly beneficial for resource-limited countries, where the burden of disease is highest. by Savannah Demko

References:

Owen A, et al. Abstract 459. Presented at: Conference on Retroviruses and Opportunistic Infections; Feb. 13-16, 2017; Seattle.

Disclosure: Infectious Disease News was unable to confirm any relevant financial disclosures at the time of publication.

Read more from the original source:
Nanomedicine provides HIV treatment alternative - Healio

PhD Research Fellow in Biophysics and Nanomedicine – Times Higher Education (THE)

A PhD research fellowship within the field of biophysics is available at the Department of Physics. The appointments have duration of 3 years with the possibility of until 1 year extension with 25% teaching duties in agreement with the department. Student should start mid-August 2017.

Information about the department The position is organized in the Department of Physics. Currently, there are 22 professors, 12 associate professors, 4 adjunct professors, 72 PhD research fellows and 15 postdoctoral positions appointed at the Department of Physics. Our research spans a broad spectrum of natural sciences and technology, which in turn allows us to offer an education providing a solid basis for future careers. Physics research is carried out in experimental as well as theoretical fields, often across conventional boundaries between disciplines. Research staff at the department makes a special effort to increase the awareness and understanding of the importance and impact of physics in our society. Further information about the department can be found at https://www.ntnu.edu/physics

Job description The PhD student will work on the project Acoustic Cluster Therapy (ACT) for improved treatment of cancer and brain diseases funded by the Research Council of Norway. This project is in collaboration with international universities and two companies Phoenix Solutions who developed a platform for ultrasound activated targeted drug delivery and Cristal therapeutics who developed a pioneering approach to transform drugs into tailor-made nanoparticles. A major challenge in cancer therapy is to obtain adequate delivery of the therapeutic agents to cancer cells, and limit the systemic exposure. The explored concepts utilize an acoustic activated cluster (microbubble/ microdroplet) system and nanoparticles to deliver a drug payload at the targeted pathology. The biodistribution of (novel) biologicals will be assessed using (fluorescence) microscopy other imaging modalities in healthy animals and disease models. In vivo MRI, ultrasound, near-infrared fluorescence (NIRF) imaging, ex vivo analyses, and histological examinations will be used to investigate the in vivo distribution and behavior of the nanoparticles.

The project involves studies in cell cultures and preclinical testing in mice, which require designing and building various experimental setups for ultrasound exposure and imaging. The student should have broad experimental experience especially with imaging techniques like confocal laser scan microscopy (CLSM) or multi photon microscopy (MPM). Knowledge of image analysis methods would be considered an asset. It is essential that the student is willing to work with laboratory animals and thus willing to obtain the FELASA license. Furthermore, it is crucial to be able to travel to workshops and for research collaboration in other EU countries as well as the USA with notice.

Qualifications The student should hold very good grades and a Master of Science in biophysics, bio (nano)technology, biomedical sciences, or related sciences.

The regulations for PhD programs at NTNU state that the applicant must have a master's degree or equivalent with at least 5 years of studies and an average grade of A or B within a scale of A-E for passing grades (A best). Candidates from universities outside Norway are kindly requested to send a Diploma Supplement or a similar document, which describes in detail the study and grade system and the rights for further studies associated with the obtained degree: http://ec.europa.eu/education/tools/diploma-supplement_en.htm

The position requires spoken and written fluency in the English language. Such evidence might be represented by the results of standard tests such as TOEFL, IELTS, Cambridge Certificate in Advanced English (CAE) or Cambridge Certificate of Proficiency in English (CPE). The candidate's language skills might also be assessed in a personal interview.

For more information about the research activities see http://www.ntnu.edu/physics/biophysmedtech/ultrasound

Terms of employment The appointment of the PhD fellows will be made according to Norwegian guidelines for universities and university colleges and to the general regulations regarding university employees. Applicants must agree to participate in organized doctoral study programs within the period of the appointment and have to be qualified for the PhD-study.

NTNUs personnel policy objective is that the staff must reflect the composition of the population to the greatest possible extent.

The position as PhD is remunerated according to the Norwegian State salary scale. There is a 2% deduction for superannuation contribution.

It is expected that the candidate can start in the position within August 2017 (but preferably not later). Further information can be obtained from Professor Catharina Davies, Department of Physics, NTNU, Phone: +47 73593688, e-mail: catharina.davies@ntnu.no or Dr. Annemieke van Wamel, Phone: +47 73593432, e-mail: annemieke.wamel@ntnu.no.

The application The application should contain: -CV -Reference letters -Certificates from Bachelor and Master degrees -List of publications or other scientific work, if any -Statement on research interest (maximum one page) -Documentation of English language proficiency (e.g. TOEFL, IELTS, etc.) if English or a Scandinavian language is not the applicant's mother tongue

Applications must be submitted electronically through this site. Applications submitted elsewhere will not be considered.

The reference number of the position is: NV-40/17

Application deadline: April 6th 2017.

About this job

About applications

Read this article:
PhD Research Fellow in Biophysics and Nanomedicine - Times Higher Education (THE)

High protein can drive weight loss – Western Wheel

 

High protein can drive weight loss
Western Wheel
He said it's important for people to eat to their body type with their goals in mind, whether that includes weight loss, hormone optimization or muscle-building. People with a lot of lean muscle mass may work better with a lot of carbs because their ...and more »

 

Continue reading here:
High protein can drive weight loss - Western Wheel

JUMPSTARTING a healthy lifestyle for 2017 – Nevada Appeal

Each year, millions of Americans make New Year's resolutions to achieve personal or professional goals. For many, that means focusing on improving health and wellness. You tell yourself this is going to be the year you join a gym, eat better or drink more water. Yet that commitment often falls short, as a recent survey suggests less than 10 percent of Americans achieve their resolutions.

There are many reasons people fall short of their goals, including setting the bar too high or being overly restrictive, which can lead to small failures and setbacks. However, there are easy ways to get back on track. A Global Water Survey, published by Nestl Waters and Kantar TNS, revealed 94 percent of American respondents believe drinking water helps maintain a healthy lifestyle.

One key to jumpstarting a healthy lifestyle is staying hydrated by drinking more water. With so much focus on food, beverage choices are often overlooked. With no calories or added sugars, water is a smart choice to stay hydrated. Here are four tips from Sarah Ladden, a registered dietitian and Director, Nutrition, Health and Wellness at Nestl Waters North America, to help you stay hydrated in 2017 and beyond.

Good habits shouldn't feel bad. Overly restrictive commitments can set you up for failure. Instead, adopt small and manageable changes to your daily routine and they can add up to big changes over time. For example, swapping just one 12-ounce (140 calorie), sugar-sweetened beverage with water each day could cut up to 50,000 calories and more than 65 cups of sugar from your diet in a year.

Replace what you lose. Adults are made up of 60 percent water, which needs to be replenished throughout the day to help you maintain a proper fluid balance. Keep water within reach all day a pitcher on the kitchen counter, a bottle in your car's center console, a refillable bottle at your desk to keep healthy hydration top of mind.

Add some sparkle to your day. Sparkling water is a great option for those who favor something other than plain water. With zero calories and no added sugar, sparkling water is a delicious, refreshing choice for healthy hydration. When entertaining, consider adding a DIY sparkling water bar to your repertoire just put out some sparkling water, sliced fruits, vegetables and herbs, and your guests can do the rest.

Turn your water bottle into your travel companion. The survey revealed that American consumers are 72 percent more likely to drink water in their cars. Whether you're commuting to work or running errands, you're constantly on the go and a bottle of water could be your best companion.

To learn more about healthy hydration, visit nestle-watersna.com/en.

Read the rest here:
JUMPSTARTING a healthy lifestyle for 2017 - Nevada Appeal

Rashaka program kicked off to help people adopt healthy lifestyle – Arab News


Arab News
 
Rashaka program kicked off to help people adopt healthy lifestyle
Arab News
Dr. Shaker A. Alomary, director of the ministry's obesity control program, said: The importance of an active and healthy lifestyle is increasingly gaining awareness among the people of Saudi Arabia. Rashaka is a key step toward the Kingdom's Vision ... 

 

See the rest here:
Rashaka program kicked off to help people adopt healthy lifestyle - Arab News

8 Tips for a Healthy Lifestyle at College – Uloop News

It may seem as if an unhealthy lifestyle is in trend away at college, but dont be convinced. It is way too easy to fall into the routine of falling asleep at 4 a.m., waking up at 9, taking 3-hour naps, and eating pizza for every meal between binge drinking.

1. Walk to class, every time

The first tip to stay away from this lifestyle is one that might seem too simple. Walk to class, every time. Do not get in the habit of getting a ride or taking the shuttle if you live close enough to your classes. It will make a huge difference in your energy and lifestyle. Get a good pair of headphones and use this time to get some quick exercise in. You may feel sluggish after a long day of sitting at a desk; this way you can feel somewhat accomplished if you decide on this quick exercise routine daily.

pexels.com

2. Take advantage of your schools gym and group workouts

If you are hesitant to go to the gym, grab a few of your friends to try out a class; many colleges provide free group classes like Zumba, kickboxing, and spin class. If it does not feel like a chore you will be more likely to do so. There are also recreational sports, club sports, and intramurals that are always very easy to join throughout your semester. Want somewhere to work out most people dont think of? Try your schools pool during free swim hours.

3. Make small changes in your diet

The dining hall might seem like a place that you will always lose your battle to maintain a healthy lifestyle. But making small changes in your diet will go a long way. For example, choose water with your meal instead of soda or juice. Try to eat as normally as you can with your schedule; it can be hard to manage eating three good meals per day, but this will cut back on your urge to snack on damaging foods. Having said this, try to buy healthy snacks at the grocery store. If you dont buy it, you wont eat it.

If you live in an apartment it may be very tempting to only eat microwavable food when you are used to relying on moms cooking or a dining hall. Cooking in a group can help motivate you to eat better, and portion sizes will make more sense to share rather than having pasta every meal for the week.

4. Make a point to go to the grocery store weekly

This way you do not become desperate and spend a lot of money and calories going out to eat every night. Take advantage of your student discount and try to refrain from buying things that are not on sale or store brand. This will save a lot of money for students on a budget.

5. Make time for a quick breakfast

Maybe combine the two tips and grab a banana and eat it on your walk to class. Something small in the morning will give you energy enough to start your day and to help stop you from overeating later. It will also motivate you to stay awake the entire day rather than breaking up your day for a nap.

6. Drink water while drinking alcohol

This is a very helpful tip to avoid a hangover and to slow yourself down if you drink more than you expected some nights. If you can have one glass of water after each drink this will do wonders for your Saturday mornings. Also, try to avoid the pizza place after the party or bar. It might seem like it doesnt count if you dont remember eating, but it unfortunately does.

We all know that college students drink. A lot. But there are a few steps to make your nights out a little bit healthier. If you drink with chasers or mixed drinks, stay away from caffeinated or overly sugary drinks like Red Bull or soda. This can also cause you to look bloated which is the last thing you want in a tight dress.

7. Watch out for stress eating

Stress eating is very common among college students. It is obvious that you are put under a lot of pressure during your years as a student and it is very easy to get into the routine of soothing your thoughts with ice cream or pizza rolls. If you continuously overeat, it will become a habit. Try to stay as far away from food as possible when you need comfort; this way you will not become addicted. There are plenty more healthy options to relieve stress.

8. Sleep

It may seem like your fellow students do not need more than four hours of sleep, but they do. Sleep is extremely important for you to be successful in any of the previous health tricks. Shoot for eight hours each night and your health will be dramatically better.

As you can tell, many of these tips do not require a huge lifestyle change. If you try and change small things in your routine, you will be that much closer to being a healthier you. Good luck!

Continue reading here:
8 Tips for a Healthy Lifestyle at College - Uloop News

Study Suggests Fresno Summer Camp Promotes Healthy Lifestyles – Valley Public Radio

A new study says a Fresno-area summer camp may help children at risk for obesity adopt healthier lifestyles.

Listen to the report here.

According to the study, families who participated in the Healthy Lifestyle and Fitness Camp in Fresno consumed more fruits and vegetables at home, and their children measured steady weight loss.

This was compared to kids who participated in non-nutrition themed summer camps. The study was published in the journal California Agriculture.

Gretchen George, assistant professor of San Francisco States Consumer, Family Studies and Dietetics Department is one of the studys authors.

George says that the intent of the camp was not to have dramatic weight loss, because six weeks is really short, but to have stabilization.

"We didnt put them on a specialized diet, or even provide food, we just made it fun, made them feel confident and good about themselves and kept them really active over the summer.

Campers received weekly lessons about nutritious food choices and preparation. They also participated in daily physical activities, like group sports or field trips. While the study assessed the camp from 2009 to 2012, the summer camp is still offered by the City of Fresnos Parks and Recreation Department.

See more here:
Study Suggests Fresno Summer Camp Promotes Healthy Lifestyles - Valley Public Radio

City, IM, Parks and Rec team up to promote healthy lifestyle – The Inter-Mountain

Elkins Mayor Van Broughton walks in the Phil Gainer Community Center. The city of Elkins, Elkins Parks and Recreation and The Inter-Mountain are promoting Marching Through March, as a way to encourage walking and physical activity during what traditionally is the last and most brutal part of the winter season.

ELKINS A new free wellness program is about to step off at the Phil Gainer Community Center, thanks to a partnership between the City of Elkins, Elkins Parks and Recreation and The Inter-Mountain.

Marching through March debuts today, as a way to encourage walking and physical activity during what traditionally is the last and most brutal part of the winter season.

We at the City of Elkins and Elkins Parks and Recreation are thrilled that The Inter-Mountain shares our commitment to lifting up the community by encouraging people to exercise more and live healthier lives, said Chris Lee, the community centers manager. For many people, staying active through the winter even a mild one like this is no easy task. Hopefully this program will encourage local residents to lace up their walking shoes for Marching through March.

The center will be open to the public from 10 a.m. to 2 p.m. every Tuesday through Thursday during March. There is no fee to participate in the walking program, and The Inter-Mountain is sponsoring $25 gift cards for four lucky individuals: one with the most steps, one with the most laps logged, oldest participant and youngest participant.

Prizes will be awarded at the conclusion of the program, which ends March 30. The deadline to submit entry forms to The Inter-Mountain 520 Railroad Ave. in downtown Elkins is April 5.

Walkers can keep track of their progress and enter the contest by filling out the form in todays Inter-Mountain.

New entry forms will be available every Friday in the Inter-Mountains Inter-Tainment guide.

Only one form is needed per participant, as this contest is based upon the cumulative total during the month-long March though Madness program.

Entry forms must be original from the newspaper and may be returned to The Inter-Mountain office at 520 Railroad Ave. Elkins, WV 26241.

Individual wellness improves the health of a community, which can play a huge role in improving overall community wellness. A community that is focused on wellness is more equipped to shed the societal issues that currently plague our community like drug addiction and various health problems, Lee said. We hope Marching through March can serve as a launching pad at the Phil Gainer Community Center to implement desirable programming that seeks to address various facets of community wellness in hopes of making Elkins a better place to live and play.

For more information, call The Inter-Mountain at 304-636-2121, ext. 104 or the center at 304-635-7151.

The facility is located at 142 Robert E. Lee Ave. Ext. near Elkins Middle School and in what used to be the armory in the city. Purchased by the city in 2016, it was recently renamed to honor Gainer, who served as the EPRC director for 42 years.

Gainer was set to retire at the end of December but unexpectedly passed away on Nov. 22 after suffering a heart attack while hunting.

Following the City Councils vote earlier in February, Mayor Van Broughton said Gainer was influential in his life and helped him reach the position to which he currently serves.

At this time, I wish I was in a council seat where I could vote on it, but I cant vote. Of course I approve of this, Broughton said. The seat Im sitting in right now, Mr. Gainer had a lot to do with it. When I was a young man and I visited the park, I saw who he was and what he was about. He and I became friends. He was one of my best friends. Its a bittersweet vote, right now, for me. Its the right thing to do.

HUNTINGTON The Sunday after the 70th West Virginia state wrestling tournament was like no other, since three ...

OAK HILL The Pocahontas County Warriors fell in a close sectional game on the road as Richwood defeated them ...

MORGANTOWN Thousands of outdoorsmen from the tri-state area will be heading to Morgantowns Mylan Park on ...

A player makes a bare-handed grab during a drill session as part of tryouts for the Elkins High School baseball ...

FRANKLIN Five Wildcats reached double digits in scoring Monday, as Pendleton County cruised past the West ...

WACO, Texas (AP) Ishmail Wainright is the lone senior for 11th-ranked Baylor, and was recognized with a video ...

See the original post:
City, IM, Parks and Rec team up to promote healthy lifestyle - The Inter-Mountain

Heart survivor advocates for heart healthy lifestyle choices – WCTV

By: Mariel Carbone February 23, 2017

TALLAHASSEE, Fla. (WCTV) At 24-years-old, Allison Locke was a nursing student at Florida State University.

She was feeling tired and sick. The doctors first attributing it to the common cold; maybe the flu. Locke thought it could be from her busy schedule, balancing school and work. But, she still felt something was wrong.

I just thought, Okay, Im just tired. But, then as is progressed I knew something was wrong, said Locke.

And she was right.

Eventually, Locke received a call from her doctors and was diagnosed with endocarditis, a bacterial infection in the lining of her heart. If left untreated, it can be fatal.

"That's the scariest thing I've ever been through, she said.

Locke went through six weeks of antibiotics and IVs around the clock. She survived, and at age 36 is now working at a nurse practitioner.

Locke said the experience was an eye opening one for her. And, although she was born with a heart murmur and mitral valve prolapse, also known as a click-murmur, she never expected this would happen.

"The last place you think to look in a healthy 24-year-old is their heart, she said.

But, for medical professionals, cardiovascular diseases are the most prominent fatal diseases.

"We're talking about the diseases or list of medical illness that kill the most people in this country every single year, said Dr. Frank Gredler, a cardiologist for Southern Medical Group and who works at Tallahassee Memorial Hospital.

Gredler is Lockes cardiologist; she visits him every six to nine months. Gredler said regular visits and living a heart healthy lifestyle are important for everyone, not just patients like Locke.

Despite the fact that we have amazing improvements in cardiovascular therapies, theres still a circumstance that one third of the people who have heart attacks have no warning symptoms. None. Until the day it happen, he said.

And, according to the American Heart Association, one person dies every 40 seconds from cardiovascular diseases.

Gredler said it is important to be aware of what medical professionals call coronary risk factors. Those include a family history of cardiovascular diseases, diabetes, hypertension, abnormal cholesterol, and cigarette smoking,

Those can increase a persons chance of having heart disease, and makes it even more important to be proactive.

Ways to be proactive include regular exercise. The American Heart Association recommends 150 minutes of physical activity a week. Gredler said anything aerobic is good for your heart, but that its important to pick an intensity level that is right for your specific situation, and something you are willing to commit to.

Theres got to be something that you say, I like doing enough that I will do it on a regular basis, he said.

Making better eating choices also adds to living a heart healthy lifestyle. Add more color to your food like fruits and vegetables; and pick nutrient-dense foods. Gredler recommends cutting sodium levels, and minimizing saturated fats.

But, the two, exercise and eating right, go hand in hand.

Incorporate eating healthy with staying active, he said.

Plus, getting regular check-ups, regardless of age, is important.

I think its important for people to have a bit of appropriate medical attention at a comfortably early stage in life. Just because youre in your twenties doesnt mean you shouldnt have your blood pressure checked, said Gredler.

Since her own experience with heart disease, Allison Locke said she has made significant changes in her own life style, including changing her diet, adding regular exercise to her week and de-stressing when necessary. Locke often uses heart healthy recipes from the American Heart Association to cook at home, including its recipe for Mexican Chicken Soup.

Its highly preventable and you can make choices like cooking healthier and getting that exercise. We all need to do that. Its not just something for when you get sick or if you have an issue. Its actually about prevention, she said.

And, aside from changes to her own lifestyle, Locke has found a passion in advocacy, sharing her story and encouraging others to make these changes, all through a platform on stage. Locke has been involved in pageantry throughout her life, choosing heart health as her philanthropy.

Shell even be competing in Mrs. Florida International in May; of course advocating for heart health as her platform.

But, unlike her time on stage, theres no do-overs when it comes to heart health.

"Life's not a dress rehearsal... you don't get a second chance, she said.

Original post:
Heart survivor advocates for heart healthy lifestyle choices - WCTV

Families need to be involved in healthy lifestyle for pre-schoolers – The Straits Times

The decision by the ministries of Health (MOH) and Education (MOE) to start physical activities and healthy eating in pre-schools is a brilliant move to curb the rising obesity trend of Singapore children (Improving kids' health: More exercise, better diet; Feb 24).

The children are at the best age to internalise what is taught.

But adults, especially teachers, have to set a good example by exercising and eating healthily, and explaining the rationale for their actions.

It is also important that the MOE be creative in the way it teaches these children the basic principles of healthy living, including the right types of food to eat.

However, the role that families play should not be forgotten (Help parents become good examples of healthy living by Dr Teoh Ren Shang; Feb 27).

All this education will be wasted if the families of these children break all the rules.

This healthier lifestyle has to be a culture in their families as well.

Only then will there be real results from the work put in by the MOH and MOE.

Leow Wen Hao

The rest is here:
Families need to be involved in healthy lifestyle for pre-schoolers - The Straits Times

WVU campaign designed to inspire healthy lifestyle choices – The Dominion Post

TheDPost.comComment Policy TheDPost.com encourages readers to engage in conversations about site content. If you would like to comment, please abide by the follow guidelines: Stay on topic:Do not include comments about other subjects. Be civil:Challenge opinions but dont personally attack or degrade others. No use of all-caps, bold or italics. Watch your language and image:No vulgarity, obscene or profane photos or language (actual or implied), including intentionally misspelling words, using characters or dashes. No frauds:Do not use the identity of a company or another person (living or dead). No free ads:Do not use comments to promote a business, money-making endeavor or individual promotion. Link limit:It is not permitted to excessively link to external sites. TheDPost.com reserves the right to remove any comment deemed unacceptable or that fails to meet our commenting guidelines. The DPost.com also reserves the right to suspend or revoke commenting privileges should a user violate the commenting guidelines. A suspension or revocation of privileges could affect the commenting privileges of others in your household.

TheDPost.com takes seriously any attempts to threaten, harass or intimidate readers and employees, and will report such behavior to authorities.

Read more:
WVU campaign designed to inspire healthy lifestyle choices - The Dominion Post

New Nano Approach Could Cut Dose of Leading HIV Treatment in … – Infection Control Today

Successful results of a University of Liverpool-led trial that utilized nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, a leading annual conference of HIV research, clinical practice and progress.

The healthy volunteer trial, conducted by the collaborative nanomedicine research program led by pharmacologist Andrew Owen and materials chemist Steve Rannard, and in collaboration with the St Stephen's AIDS Trust at the Chelsea & Westminster Hospital in London, examined the use of nanotechnology to improve the delivery of drugs to HIV patients. The results were from two trials which are the first to use orally dosed nanomedicine to enable HIV therapy optimization.

Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanomedicine is the application of nanotechnology to the prevention and treatment of disease in the human body. By developing smaller pills that are better for patients and less expensive to manufacture, this evolving discipline has the potential to dramatically change medical science and is already having an impact in a number of clinically used therapies and diagnostics worldwide.

Currently, the treatment of HIV requires daily oral dosing of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies.

Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.

The trial results confirmed the potential for a 50 percent dose reduction while maintaining therapeutic exposure, using a novel approach to formulation of two drugs: efavirenz (EFV) and, lopinavir (LPV). EFV is the current WHO-recommended preferred regimen, with 70% of adult patients on first-line taking an EFV-based HIV treatment regimen in low- and middle-income countries.

The trial is connected to the University's ongoing work as part of the multinational consortium OPTIMIZE, a global partnership working to accelerate access to simpler, safer and more affordable HIV treatment. Funded by the U.S. Agency for International Development, OPTIMIZE is led by the Wits Reproductive Health & HIV Institute in Johannesburg, South Africa, and includes the interdisciplinary Liverpool team, Columbia University, Mylan Laboratories and the Medicines Patent Pool (MPP). OPTIMIZE is supported by key partners including UNITAID and the South African Medical Research Council (SAMRC)

Benny Kottiri, USAID's Office of HIV/AIDS Research Division Chief, said: "The potential applications for HIV treatment are incredibly promising. By aligning efforts, these integrated investments offer the potential to reduce the doses required to control the HIV virus even further, resulting in real benefits globally. This would enable the costs of therapy to be reduced which is particularly beneficial for resource-limited countries where the burden of disease is highest."

Source: University of Liverpool

The rest is here:
New Nano Approach Could Cut Dose of Leading HIV Treatment in ... - Infection Control Today

What Do Your Tears Say About Your Health? – Chromatography Today

Some are happy, most are sad and others are just a result of chopping onions. Yes, tears. Psychiatrists could probably spend hours telling you what your tears mean for your mental health. But the little watery droplets are usually seen as fruitless for physical information. However, a team of scientists at Michigan Technological University may have changed that. Read on to see how tears can be used for medical testing.

Despite the perception of tears as empty and invaluable, they might contain important nutritional information. At present, the only way to access patients nutritional information, like vitamin levels, is through invasive (and expensive) blood tests. And it was this that led the team at Michigan Tech to their main question are there links between tear content and nutritional values in blood?

"We hypothesized that nutrients are transferred to the living cells of your cornea through your tears," explains Michigan Tech research specialist Maryam Khaksari. "We would like to translate the information we have for blood to tears. The link is certainly possible, with previous studies finding people with vitamin deficiencies blink more than those without.

To test the link, they focussed on three vitamins A, B and E. After taking samples of the tears and blood from 15 babies aged four-months as well as their parents, they used liquid chromatography and mass spectrometry to assess the content of the samples. Improved analytical development for this method is explored in the article, Capillary Flow LC-MS Unites Sensitivity and Throughput.

Overall, the results showed that levels of fat-soluble vitamins were higher in parents, while water-soluble vitamins were seen more in babies. There was a connection between the vitamin levels in parents and babies, with a correlation between vitamins B and E also shown by the results.

However, whats more significant is the promise this research shows in using tears for vitamin research. In this paper, we did show that there are correlations between vitamin concentrations in tears and bloodso it's possible," says Khaksari. The next step is to develop a device capable of performing these tests.

This project was the first step that proved vitamins are detectable in tears, that they do correlate with blood levels. Next we want to engineer a portable, lab-on-a-chip device relying on a minimally invasive sample from tears to assess nutrition, said Adrienne Minerick, professor of chemical engineering at Michigan Tech.

Looks like our parents were wrong when they said crying wont help.

Excerpt from:
What Do Your Tears Say About Your Health? - Chromatography Today

New Technique Cuts HIV Treatment in Half – Controlled Environments Magazine

Successful results of a University of Liverpool-led trial that utilized nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, a leading annual conference of HIV research, clinical practice, and progress.

The healthy volunteer trial, conducted by the collaborative nanomedicine research program led by Pharmacologist Professor Andrew Owen and Materials Chemist Professor Steve Rannard, and in collaboration with the St Stephens AIDS Trust at the Chelsea & Westminster Hospital in London, examined the use of nanotechnology to improve the delivery of drugs to HIV patients. The results were from two trials which are the first to use orally dosed nanomedicine to enable HIV therapy optimization.

Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanomedicine is the application of nanotechnology to the prevention and treatment of disease in the human body. By developing smaller pills that are better for patients and less expensive to manufacture, this evolving discipline has the potential to dramatically change medical science and is already having an impact in a number of clinically used therapies and diagnostics worldwide.

Currently, the treatment of HIV requires daily oral dosing of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies.

Recent evaluation of HIV patient groups has shown a willingness to switch to nanomedicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.

The trial results confirmed the potential for a 50 percent dose reduction while maintaining therapeutic exposure, using a novel approach to formulation of two drugs: efavirenz (EFV) and, lopinavir (LPV). EFV is the current WHO-recommended preferred regimen, with 70 percent of adult patients on first-line taking an EFV-based HIV treatment regimen in low- and middle-income countries.

The trial is connected to the Universitys ongoing work as part of the multinational consortium OPTIMIZE, a global partnership working to accelerate access to simpler, safer and more affordable HIV treatment. Funded by the U.S. Agency for International Development, OPTIMIZE is led by the Wits Reproductive Health & HIV Institute in Johannesburg, South Africa, and includes the interdisciplinary Liverpool team, Columbia University, Mylan Laboratories, and the Medicines Patent Pool (MPP). OPTIMIZE is supported by key partners including UNITAID and the South African Medical Research Council (SAMRC).

Benny Kottiri, USAIDs Office of HIV/AIDS Research Division Chief, says, The potential applications for HIV treatment are incredibly promising. By aligning efforts, these integrated investments offer the potential to reduce the doses required to control the HIV virus even further, resulting in real benefits globally. This would enable the costs of therapy to be reduced which is particularly beneficial for resource-limited countries where the burden of disease is highest.

Source: University of Liverpool

More:
New Technique Cuts HIV Treatment in Half - Controlled Environments Magazine

New nano approach could cut dose of leading HIV treatment in half – Phys.Org

February 21, 2017 Credit: University of Liverpool

Successful results of a University of Liverpool-led trial that utilised nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, a leading annual conference of HIV research, clinical practice and progress.

The healthy volunteer trial, conducted by the collaborative nanomedicine research programme led by Pharmacologist Professor Andrew Owen and Materials Chemist Professor Steve Rannard, and in collaboration with the St Stephen's AIDS Trust at the Chelsea & Westminster Hospital in London, examined the use of nanotechnology to improve the delivery of drugs to HIV patients. The results were from two trials which are the first to use orally dosed nanomedicine to enable HIV therapy optimisation.

Manipulation of matter

Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanomedicine is the application of nanotechnology to the prevention and treatment of disease in the human body. By developing smaller pills that are better for patients and less expensive to manufacture, this evolving discipline has the potential to dramatically change medical science and is already having an impact in a number of clinically used therapies and diagnostics worldwide.

Currently, the treatment of HIV requires daily oral dosing of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies.

Developing new therapies

Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.

The trial results confirmed the potential for a 50 percent dose reduction while maintaining therapeutic exposure, using a novel approach to formulation of two drugs: efavirenz (EFV) and, lopinavir (LPV). EFV is the current WHO-recommended preferred regimen, with 70% of adult patients on first-line taking an EFV-based HIV treatment regimen in low- and middle-income countries.

The trial is connected to the University's ongoing work as part of the multinational consortium OPTIMIZE, a global partnership working to accelerate access to simpler, safer and more affordable HIV treatment. Funded by the U.S. Agency for International Development, OPTIMIZE is led by the Wits Reproductive Health & HIV Institute in Johannesburg, South Africa, and includes the interdisciplinary Liverpool team, Columbia University, Mylan Laboratories and the Medicines Patent Pool (MPP). OPTIMIZE is supported by key partners including UNITAID and the South African Medical Research Council (SAMRC).

Potential applications

Benny Kottiri, USAID's Office of HIV/AIDS Research Division Chief, said: "The potential applications for HIV treatment are incredibly promising. By aligning efforts, these integrated investments offer the potential to reduce the doses required to control the HIV virus even further, resulting in real benefits globally. This would enable the costs of therapy to be reduced which is particularly beneficial for resource-limited countries where the burden of disease is highest."

Explore further: New nanomedicine approach aims to improve HIV drug therapies

More information: The presentation is available online: http://www.croiwebcasts.org/console/player/33376?mediaType=slideVideo&

As devices become smaller and more powerful, they require faster, smaller, more stable batteries. University of Illinois chemists have developed a superionic solid that could be the basis of next-generation lithium-ion batteries.

Cells within our bodies divide and change over time, with thousands of chemical reactions occurring within each cell daily. This makes it difficult for scientists to understand what's happening inside. Now, tiny nanostraws ...

DNA, the stuff of life, may very well also pack quite the jolt for engineers trying to advance the development of tiny, low-cost electronic devices.

Drugs disguised as viruses are providing new weapons in the battle against cancer, promising greater accuracy and fewer side effects than chemotherapy.

The precise control of electron transport in microelectronics makes complex logic circuits possible that are in daily use in smartphones and laptops. Heat transport is of similar fundamental importance and its control is ...

A new technique using liquid metals to create integrated circuits that are just atoms thick could lead to the next big advance for electronics.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Link:
New nano approach could cut dose of leading HIV treatment in half - Phys.Org

Nominations invited for $250000 Kabiller Prize in Nanoscience and Nanomedicine – Northwestern University NewsCenter

EVANSTON - Northwestern Universitys International Institute for Nanotechnology (IIN) is now accepting nominations for two prestigious international prizes: the $250,000 Kabiller Prize in Nanoscience and Nanomedicine and the $10,000 Kabiller Young Investigator Award in Nanoscience and Nanomedicine.

The deadline for nominations is May 15, 2017. Details are available on the IIN website.

Our goal is to recognize the outstanding accomplishments in nanoscience and nanomedicine that have the potential to benefit all humankind, said David G. Kabiller, a Northwestern trustee and alumnus. He is a co-founder of AQR Capital Management, a global investment management firm in Greenwich, Connecticut.

The two prizes, awarded every other year, were established in 2015 through a generous gift from Kabiller. Current Northwestern-affiliated researchers are not eligible for nomination until 2018 for the 2019 prizes.

The Kabiller Prize the largest monetary award in the world for outstanding achievement in the field of nanomedicine celebrates researchers who have made the most significant contributions to the field of nanotechnology and its application to medicine and biology.

The Kabiller Young Investigator Award recognizes young emerging researchers who have made recent groundbreaking discoveries with the potential to make a lasting impact in nanoscience and nanomedicine.

The IIN at Northwestern University is a hub of excellence in the field of nanotechnology, said Kabiller, chair of the IIN executive council and a graduate of Northwesterns Weinberg College of Arts and Sciences and Kellogg School of Management. As such, it is the ideal organization from which to launch these awards recognizing outstanding achievements that have the potential to substantially benefit society.

Nanoparticles for medical use are typically no larger than 100 nanometers comparable in size to the molecules in the body. At this scale, the essential properties (e.g., color, melting point, conductivity, etc.) of structures behave uniquely. Researchers are capitalizing on these unique properties in their quest to realize life-changing advances in the diagnosis, treatment and prevention of disease.

Nanotechnology is one of the key areas of distinction at Northwestern, said Chad A. Mirkin, IIN director and George B. Rathmann Professor of Chemistry in Weinberg. We are very grateful for Davids ongoing support and are honored to be stewards of these prestigious awards.

An international committee of experts in the field will select the winners of the 2017 Kabiller Prize and the 2017 Kabiller Young Investigator Award and announce them in September.

The recipients will be honored at an awards banquet Sept. 27 in Chicago. They also will be recognized at the 2017 IIN Symposium, which will include talks from prestigious speakers, including 2016 Nobel Laureate in Chemistry Ben Feringa, from the University of Groningen, the Netherlands.

The winner of the inaugural Kabiller Prize, in 2015, was Joseph DeSimone the Chancellors Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill and the William R. Kenan Jr. Distinguished Professor of Chemical Engineering at North Carolina State University and of Chemistry at UNC-Chapel Hill.

DeSimone was honored for his invention of particle replication in non-wetting templates (PRINT) technology that enables the fabrication of precisely defined, shape-specific nanoparticles for advances in disease treatment and prevention. Nanoparticles made with PRINT technology are being used to develop new cancer treatments, inhalable therapeutics for treating pulmonary diseases, such as cystic fibrosis and asthma, and next-generation vaccines for malaria, pneumonia and dengue.

Warren Chan, professor at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, was the recipient of the inaugural Kabiller Young Investigator Award, also in 2015. Chan and his research group have developed an infectious disease diagnostic device for a point-of-care use that can differentiate symptoms.

In total, the IIN represents and unites more than $1 billion in nanotechnology infrastructure, research and education. These efforts, plus those of many other groups, have helped transition nanomedicine from a laboratory curiosity to life-changing technologies that are positively impacting the world.

The IIN houses numerous centers and institutes, including the Ronald and JoAnne Willens Center for Nano Oncology, an NIH Center of Cancer Nanotechnology Excellence, an Air Force Center of Excellence for Advanced Bioprogrammable Nanomaterials, and the Convergence Science & Medicine Institute.

More here:
Nominations invited for $250000 Kabiller Prize in Nanoscience and Nanomedicine - Northwestern University NewsCenter

Global Nanomedicine Market Is Primarily Driven by an Increase in the Rate of Investments Made Into It – Digital Journal

Transparency Market Research Report Added "Nanomedicine Market - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019"

This press release was orginally distributed by SBWire

Albany, NY -- (SBWIRE) -- 02/14/2017 -- The global nanomedicine market will exhibit a CAGR of 12.3% within a forecast period of 2013 to 2019. The market was valued at US$78.54 bn in 2012 and is expected to reach US$177.60 bn before the end of 2019, according to a research report released by market intelligence firm, Transparency Market Research. The report, titled "Nanomedicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," holds vital data on this market for to help the market stakeholders in strategic planning in the near future.

Download PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1753

According to the data given in the report, the global nanomedicine market is primarily driven by an increase in the rate of investments made into it. These investments are coming in the form of government support and collaborations within the healthcare industry. Most of the investments are made to improve the research and development efforts in the global nanomedicine market.The high rate of investments is being made to complement the rising prevalence of chronic diseases, which is increasing the number of patients with unresolved medical requirements.

Major restraints on the global nanomedicine market, as stated in the report, are the high costs associated with the development of effective nanomedicine, along with the overall insufficiency of framework in terms of regulatory guidance.The future of the global nanomedicine market could rely on a growing trend of identifying new applications in nanomedicine, along with its increasing scope of use in emerging economies.

The report provides a segmented analysis of the global nanomedicine market in terms of applications and geography.In terms of applications, the global nanomedicine market was led by the oncology segment in 2012, when it held nearly 38.0% of the market. Oncology holds a high percentage of nanomedicine use in the commercialized sense, allowing it to hold the largest share in the global nanomedicine market. The report, however, states that the oncology segment will lose market share to the cardiovascular segment, which is growing at the fastest rate due to an increasing population of geriatric citizens around the world.

The regional analysis of the global nanomedicine market provided in the report reveals Asia Pacific to exhibit the fastest CAGR of 14.6% between 2013 and 2019. This region owes its rapid growth rate to the increase in awareness of the benefits of nanomedicine usage in the treatment of chronic diseases. This is more relevant to China and India, where the growing rate of diagnosis of chronic illnesses, coupled with the increase in healthcare expenditure and collaborative efforts, is promoting the use of nanomedicine.

Till 2012, the global nanomedicine market was led by North America owing to the highly advanced infrastructure and services present in the healthcare industry. The report suggests that North America will maintain its dominance over the global nanomedicine market for the given forecast period.

The key players in the global nanomedicine market are Teva Pharmaceutical Industries Ltd., Sigma-Tau Pharmaceuticals Inc., UCB SA, Nanosphere Inc., Pfizer Inc., GE Healthcare, Merck & Co. Inc., Johnson & Johnson, Mallinckrodt plc, Celgene Corporation, Abbott Laboratories, and CombiMatrix Corp.

About Transparency Market Research Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us Transparency Market Research State Tower, 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com

For more information on this press release visit: http://www.sbwire.com/press-releases/global-nanomedicine-market/release-766924.htm

Read the rest here:
Global Nanomedicine Market Is Primarily Driven by an Increase in the Rate of Investments Made Into It - Digital Journal